FDA grants accelerated approval for first engineered T cell therapy to treat adults with synovial sarcoma

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma.

No Aspirin Needed After LVAD, ARIES-HM3 Trial Says

PHILADELPHIA — Dropping aspirin from the antithrombotic regimen after HeartMate 3 left ventricular assist device (LVAD) implantation appeared safer than the usual combination approach in

November 12, 2023

FDA approves PureTech’s KarXT to treat schizophrenia in adults

KarXT is designed for the treatment of schizophrenia in adults. Credit: BlurryMe via Shutterstock. Puretech Health has obtained approval from the US Food and Drug

September 30, 2024

FDA says four doses of Lilly’s diabetes drug Mounjaro will be in short supply through April

The FDA said Tuesday that shortages of three higher doses of Eli Lilly’s type 2 diabetes drug Mounjaro aren’t expected to ease until May, and

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.